Blood Grouping Reagents Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments, Service And Software), By Technique (PCR-based and Microarray Technique, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology, Other Techniques), By Test Type (Blood Group and Phenotype, Antibody Screening, Cross-matching Tests, Antibody Identification, Coombs Tests, Antigen Typing), By End-User (Hospitals and Blood Banks, Clinical Laboratories, Academic and Research Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Blood Grouping Reagents Market Size

The global blood grouping reagents market size was valued at USD 2.45 billion in 2025 and is projected to grow from USD 2.64 billion in 2026 to USD 4.87 billion by 2034, registering a CAGR of 7.94% during the forecast period from 2026 to 2034. North America dominated the blood grouping reagents market with a market share of 38.2% in 2025.

Several factors are driving the growth of the blood grouping reagents market, including blood donation campaigns, an increase in the incidence rate of various diseases, an increase in government initiatives regarding the need for blood donation, an urgent need for blood during surgical procedures, and safe blood transfusions.

Blood grouping reagents are substances used to identify human blood group antigens (like ABO, Rhesus, Kell, and MNS blood group antigens). The ABO and RhD blood group systems are the most crucial in transfusions. On the surface of the human red cell, blood groups are distinguished by a carbohydrate molecule (like the ABO blood group antigens) or a protein molecule (such as the majority of other antigens).

The ABO system contains antigens A and B; whereas the RhD system contains antigens D. There are four ABO blood group classifications, i.e., O, A, B, and AB. The RhD reagents detect the absence or presence of antigen D on the surface of human red blood cells (RBCs). Anti-A, Anti-B, and Anti-A, B reagents are utilized to identify the ABO blood group. In contrast, the various anti-D reagents are used to identify the rhesus D phenotype. Anti-K and Anti-K (Cellano) reagents detect antigens belonging to the Kell blood group system.

Segmentation Analysis

By Product

The global market is segmented into consumables, instruments, software & services.

Consumables, including reagents and test kits, dominate the blood grouping reagents market due to their essential role in blood grouping tests. These consumables are critical for determining an individual's blood type and compatibility for transfusions and transplants. Manufacturers like Bio-Rad Laboratories, Inc., Grifols, and Immucor, Inc., are key players in providing consumables for blood grouping tests. For example, Bio-Rad Laboratories offers a wide range of blood typing reagents and kits, including its IH-Combi Plex range, known for its reliability and accuracy. The dominance of consumables is supported by the consistent demand for these products in healthcare settings worldwide.

Request Customizationto receive a tailored report.

By Technique

The global market is segmented into PCR-based and microarray techniques, assay-based techniques, massively parallel sequencing techniques, serology, and other techniques.

PCR-based and microarray techniques are dominant in the blood grouping reagents market due to their high sensitivity and specificity in detecting blood group antigens and antibodies. These techniques allow for the rapid and accurate typing of blood samples, making them invaluable in blood transfusion services and transplantation. Manufacturers like Grifols, Bio-Rad Laboratories, and Ortho Clinical Diagnostics offer PCR-based and microarray techniques for blood grouping. For instance, Ortho Clinical Diagnostics' ORTHO BioVue System is known for its high-throughput capabilities and accuracy in blood typing. The dominance of PCR-based and microarray techniques is supported by their widespread adoption in clinical laboratories and blood banks worldwide.

By Test Type

The global market is segmented into blood group and phenotype, antibody screening, cross-matching tests, antibody identification, Coombs tests, and antigen typing.

Antibody screening is a dominant test type in the blood grouping reagents market, as it plays a crucial role in detecting unexpected antibodies that can cause adverse reactions during blood transfusions. Manufacturers like Immucor, Inc., Bio-Rad Laboratories, and Quotient Limited offer a range of reagents and kits for antibody screening tests. For example, Immucor's Capture-R Ready-Screen Kit is widely used for its efficiency in detecting unexpected antibodies. The dominance of antibody screening is supported by its importance in ensuring safe and compatible blood transfusions, making it a standard practice in blood banks and clinical laboratories worldwide.

By End User

The global market is segmented into hospitals and blood banks, clinical laboratories, and academic and research institutes.

Hospitals are the dominant end-users of blood grouping reagents due to the high volume of blood grouping tests performed in hospital settings, particularly for patients requiring transfusions and surgeries. The Centers for Disease Control and Prevention (CDC) report highlights that the hospitals perform a significant number of blood transfusions annually, showcasing the importance of blood grouping tests in these settings. Manufacturers often tailor their products to meet the specific needs of hospitals, offering reliable and efficient reagents and instruments.

• For instance, Grifols provides hospitals with its Erytra and DG Gel systems, known for their accuracy and ease of use in blood typing. The dominance of hospitals as end-users is supported by their role as major healthcare providers and the central hub for blood transfusion services.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America: Dominant Region with A Significant Market Share

North America is the most significant global blood grouping reagents market shareholder and is expected to expand substantially over the forecast period. Numerous factors have contributed to the increasing prevalence of blood grouping reagents in North America. The market for blood grouping reagents in North America is anticipated to expand in the coming years because of the prevalence of chronic diseases, an aging population, and the number of surgical procedures. This necessitates using blood grouping reagents for accurate blood grouping and cross-matching. In addition, the rising need for blood transfusions across the region can be linked to the rising demand for blood grouping reagents. For instance, according to givingblood.org, 4.5 million Americans will require blood transfusions annually by 2023. In the United States and Canada, 43,000 pints of donated blood are utilized daily.

Furthermore, North America is renowned for its advanced healthcare systems and technological advancements. Automated blood typing systems and point-of-care diagnostic devices, which require compatible blood grouping reagents, have been adopted in the region. These advancements enhance efficiency, accuracy, and patient outcomes. Collaborations and partnerships between blood banks, healthcare providers, and manufacturers of blood classification reagents have also emerged in North America. These collaborations seek to improve the research, development, and adoption of advanced blood grouping reagents, accelerating market expansion. For instance, Bio-Rad Laboratories announced a partnership with Seegene in 2021 to manufacture and market molecular diagnostic instruments for infectious diseases.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific: Fastest Growing Region

The Asia-Pacific market is anticipated to experience a significant growth pace due to the rise in the prevalence and incidence of chronic disorders in Asian nations. Asia-Pacific is predicted to have the quickest expansion rate for the blood grouping reagents market. The expansion of this market is being driven by rising public awareness of blood donation, government efforts, and rising demand for blood banking services. The tenth largest cause of death worldwide is car accidents.

Additionally, the rising number of traumatic injuries from accidents and other trauma in the area is one of the major reasons influencing the market's expansion. India had one of the highest rates of road accidents in the world in 2019, with around 500,000 incidents, resulting in 150,000 fatalities and 300,000 permanent disabilities. According to figures from the transport ministry, there were 467,044 registered road accidents in India in 2018, up 0.5% from 464,910 in 2017. Similarly, the National Bureau of Statistics of China reported 63,194 fatal road accidents in 2018. The need for blood grouping reagents in the region is expected to rise due to the high number of traffic accidents that result in severe injuries.

List of Key and Emerging Players in Blood Grouping Reagents Market